PCI in Cardiology
Conditions
Interventions
None listed
Sponsors
Oklahoma State University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: To be included in our study, the study design must be a systematic review andor metaanalysis. We will use the PRISMAP definition of a systematic review/meta-analysis which states that a systematic review is a systematic review is a review of a clearly formulated question that uses systematic and explicit methods to identify select and critically appraise relevant research and to collect and analyze data from the studies that are included in the review. Statistical methods may or may not be used to analyze and summarize the results of the included studies. Metaanalysis refers to the use of statistical techniques in a systematic review to integrate the results of included studies. Furthermore studies will be included if they compare stent placement to a pharmacologic therapy or nonpharmacologic therapy such as behavioral changes. Furthermore to qualify for inclusion systematic reviews must have been published between September of 2016 and December of 2019. Only systematic reviews published in English and reviews that synthesize studies of human or animal data will be included.
Exclusion criteria
Exclusion criteria: To be included in our study, the study design must be a systematic review andor metaanalysis. We will use the PRISMAP definition of a systematic review/meta-analysis which states that a systematic review is a systematic review is a review of a clearly formulated question that uses systematic and explicit methods to identify select and critically appraise relevant research and to collect and analyze data from the studies that are included in the review. Statistical methods may or may not be used to analyze and summarize the results of the included studies. Metaanalysis refers to the use of statistical techniques in a systematic review to integrate the results of included studies. Furthermore studies will be included if they compare stent placement to a pharmacologic therapy or nonpharmacologic therapy such as behavioral changes. Furthermore to qualify for inclusion systematic reviews must have been published between September of 2016 and December of 2019. Only systematic reviews published in English and reviews that synthesize studies of human or animal data will be included.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We focused this study on the association of FCOIs within SRMAs investigating trials of PCIs. | — |
Countries
North America
Contacts
Public ContactMatt Vassar
Oklahoma State University CHS
Outcome results
None listed